REQUEST A DEMO
Total
USD $0.00
Search more companies

Apoteka Alba Graeca Pharm (Serbia)

Main Activities: Department Stores
Full name: Apoteka Alba Graeca Pharm Profile Updated: October 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Apoteka Alba Graeca Pharm is an enterprise in Serbia, with the main office in Belgrade. The company operates in the Department Stores industry. It was first established on 2004. Apoteka Alba Graeca Pharm currently employs 46 (2023) people. The company’s latest financial report indicates a net sales revenue increase of 15.3% in 2023. Its’ total assets recorded a growth of 40.22%. In, 2023, the company’s net profit margin decreased by 0.13%.

Headquarters
Ulofa Palmea 3
Belgrade; Belgrade; Postal Code: branaalba@open.telekom.rs

Contact Details: Purchase the Apoteka Alba Graeca Pharm report to view the information.

Website: http://CUBE_PROFILES_YU

Basic Information
Total Employees:
Purchase the Apoteka Alba Graeca Pharm report to view the information.
Outstanding Shares:
Purchase the Apoteka Alba Graeca Pharm report to view the information.
Registered Capital:
Purchase the Apoteka Alba Graeca Pharm report to view the information.
Incorporation Date:
2004
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Tropic Uno
10%
Company Performance
Financial values in the chart are available after Apoteka Alba Graeca Pharm report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
15.3%
Total operating revenue
14.77%
Operating profit (EBIT)
8.32%
EBITDA
8.01%
Net Profit (Loss) for the Period
5.35%
Total assets
40.22%
Total equity
14.73%
Operating Profit Margin (ROS)
-0.16%
Net Profit Margin
-0.13%
Return on Equity (ROE)
-1.84%
Debt to Equity Ratio
91.7%
Quick Ratio
0.03%
Cash Ratio
0.13%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?